Browse studies
Find your next paid study
16 recruiting studies matching your filters
Observational
Improving Breast Cancer Patients' Self-Efficacy and Sexual Health Quality of Life
Approximately 200 English- or Spanish-speaking women newly diagnosed with stage I-III breast cancer will be randomized to either receive access to an online se…
Breast Cancer FemalesNewly Diagnosed Breast Cancer
Estimated
~$10 – $6,250
University of Colorado, DenverNCT07434817
Phase 3
A Phase 3, Randomized, Open-label Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
The purpose of this Phase 3 study is to evaluate if BRd prolongs progression free survival (PFS) and/or improves minimal residual disease (MRD) negative status…
Multiple MyelomaNewly Diagnosed Multiple Myeloma
Estimated
~$10 – $7,500
GlaxoSmithKlineNCT06679101
Phase 1
Delivery of D2C7-IT and 2141-V11 Combination Immunotherapy in Residual Disease for Adult Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma and Perilymphatic Subcutaneous Injections of 2141-V11
The purpose of this research study is to determine the safety and efficacy of administering a single intracerebral (within the brain) dose of investigational c…
Newly Diagnosed MGMT Unmethylated Glioblastoma
Estimated
~$10 – $7,500
Darell BignerNCT05734560
Phase 1
A Phase 1 Study of Bispecific T Cell Engager (BRiTE) in Patients With Newly Diagnosed or Recurrent Glioblastoma
This Phase 1 study will assess the safety of a novel brain Bispecific T cell engager (BRiTE) in patients with newly diagnosed or recurrent World Health Organiz…
Newly Diagnosed GlioblastomaRecurrent Glioblastoma
Estimated
~$10 – $7,500
Mustafa Khasraw, MBChB, MD, FRCP, FRACPNCT04903795